Back to results
US 2023/0390252 A1Published application
Use of riluzole prodrugs to treat ataxias
AssigneeBiohaven Therapeutics Ltd.
InventorsVladimir CORIC, Robert BERMAN, Melissa BEINER, Gilbert L'Italien
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of treating ataxia by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
Claims15
1-18. (canceled)
A method of treating spinocerebellar ataxia type 3 in a patient, comprising administering to the patient in need of such treatment a therapeutically effective amount of a riluzole prodrug having the following formula:
- or pharmaceutically acceptable salts thereof, wherein:
- R23 is selected from the group consisting H, CH3, CH2CH3, CH2CH2CH3, CH2CCH, CH(CH3)2, CH2CH(CH3)2, CH(CH3)CH2CH3, CH2OH, CH2OCH2Ph, CH2CH2OCH2Ph, CH(OH)CH3, CH2Ph, CH2(cyclohexyl), CH2(4-OH-Ph), (CH2)4NH2, (CH2)3NHC(NH2)NH, CH2(3-indole), CH2(5-imidazole), CH2CO2H, CH2CH2CO2H, CH2CONH2, and CH2CH2CONH2.
Dependencies are inferred from the claim text.